ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
POINT Biopharma Debuts as Publicly Traded Next-Generation Radiotherapeutics Company
July 01, 2021POINT Biopharma Inc. ("POINT") today announced the completion of its business combination with Therapeutics Acquisition Corp., d/b/a Research Alliance Corp. -
Research Alliance Corp. I Announces Effectiveness of Registration Statement for Proposed Business Combination with POINT
June 10, 2021Therapeutics Acquisition Corp, d/b/a Research Alliance Corp. I, a Delaware corporation ("the Company") (Nasdaq: RACA) announced today that its registration statement on Form S-4 (File Number 333-254600) (as amended, the "Registration Statement"
Pharma Sources Insight January 2025
